2020
Hepatitis Delta Virus
histone mimicry drives the recruitment of chromatin remodelers for viral RNA
replication. Abeywickrama-Samarakoon N, Cortay JC, Sureau C, Müller S, Alfaiate
D, Guerrieri F, Chaikuad A, Schröder M, Merle P, Levrero M, Dény P. Nat Commun.
2020 Jan 21;11(1):419. doi: 10.1038/s41467-020-14299-9.
A combined small molecule and
loss-of-function screen uncovers estrogen 2 receptor alpha and CAD as host
factors for HDV infection and antiviral targets. Verrier ER,…, Zeisel MB,…,
Baumert TF. Gut 2020; 69(1):158-167. doi: 10.1136/gutjnl-2018-317065.
A functional microRNA
screen uncovers O-linked N-acetylglucosamine transferase as a host factor
modulating hepatitis C virus morphogenesis and infectivity. Herzog K, Bandiera
S,..., Zeisel MB. Gut 2020; 69(2):380-392. doi: 10.1136/gutjnl-2018-317423.
2019
Serum hepatitis B
core-related antigen (HBcrAg) correlates with covalently closed circular DNA
transcriptional activity in chronic hepatitis B patients. Testoni B, Lebossé F,
Scholtes C, Berby F, Miaglia C, Subic M, Loglio A, Facchetti F, Lampertico P,
Levrero M, Zoulim F. J Hepatol. 2019 Apr;70(4):615-625. doi:
10.1016/j.jhep.2018.11.030.
The novel HBx mutation
F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B
virus replicative efficiency and enhances anti-apoptotic activity of HBx
N terminus in vitro. Salpini R,…, Levrero M,…, Svicher V. Clin Microbiol.
Infect. 2018 Nov;pii: S1198-743X(18)30744-4. doi: 10.1016/j.cmi.2018.11.017.
Inducing and Characterizing Vesicular
Steatosis in Differentiated HepaRG Cells. Di Cocco S, Belloni L, Nunn ADG,
Salerno D, Piconese S, Levrero M, Pediconi N. J Vis Exp. 2019 Jul 18;(149).
doi: 10.3791/59843.
EZH2, JMJD3, and UTX epigenetically
regulate hepatic plasticity inducing retro-differentiation and proliferation of
liver cells. Pediconi N, Salerno D, Lupacchini L, Angrisani A, Peruzzi G, De Smaele
E, Levrero M, Belloni L. Cell Death Dis. 2019 Jul 8;10(7):518. doi:
10.1038/s41419-019-1755-2.
Effect of food preservatives and
additives in promoting intestinal inflammation. Laudisi F, Di Fusco D, Dinallo
V, Stolfi C, Di Grazia A, Marafini I, Colantoni A, Ortenzi A, Alteri C,
Guerrieri F, Ceccherini-Silberstein F, Federici M, Monteleone I, and Monteleone
G. Cell Mol Gastroenterol Hepatol. 2019;7(2):457-473. doi:
10.1016/j.jcmgh.2018.09.002.
Microglia-Derived Microvesicles Affect
Microglia Phenotype in Glioma. Grimaldi A, Serpe C, Chece G, Nigro V, Sarra A,
Ruzicka B, Relucenti M, Familiari G, Ruocco G, Pascucci GR, Guerrieri F,
Limatola C, Catalano M. Front Cell Neurosci. 2019 Feb;13:41. doi:
10.3389/fncel.2019.00041.
HCV-induced epigenetic changes associated
with liver cancer risk persist after sustained virologic response. Hamdane N,
Jühling F,…, Zeisel MB,…, Baumert TF. Gastroenterology. 2019
Jun;156(8):2313-2329.e7. doi:10.1053/j.gastro.2019.02.03.
In vivo combination of human
anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for
prevention of hepatitis C virus infection. Mailly L, Wrensch F, Heydmann L,
Fauvelle C, Brignon N, Zeisel MB, Pessaux P, Keck ZY, Schuster C, Fuerst TR,
Foung SKH, Baumert TF. Antiviral Res. 2019 Feb;162:136-141. doi:
10.1016/j.antiviral.2018.12.018.
Combined analysis of metabolome,
proteomes, and transcriptomes of HCV-infected cells and liver to identify
pathways associated with disease development. Lupberger J,…, Zeisel MB,…,
Baumert TF. Gastroenterology. 2019 Apr;pii: S0016-5085(19)35670-7. doi:
10.1053/j.gastro.2019.04.003.
IFITMs mediate viral evasion in acute
and chronic hepatitis C virus infection. Wrensch F, Ligat G, Heydmann L,
Schuster C, Zeisel MB, Pessaux P, Habersetzer F, King BJ, Tarr AW, Ball JK,
Winkler M, Pöhlmann S, Keck ZY, Foung KH, Baumert TF. Hepatology. 2019 May;doi:
10.1002/hep.30699.
A global scientific strategy to cure
hepatitis B. Revill PA,…, Levrero M,…, Thimme R. Lancet Gastroenterol Hepatol.
2019 Apr; pii: S2468-1253(19)30119-0. doi: 10.1016/S2468-1253(19)30119-0.
Review.
Update of the statements on biology and
clinical impact of occult hepatitis b virus infection. Raimondo G, Locarnini S,
Pollicino T, Levrero M, Zoulim F, Lok AS. J Hepatol. 2019 Apr; pii:
S0168-8278(19)30259-4. doi: 10.1016/j.jhep.2019.03.034. Review.
Non-invasive biomarkers for chronic
hepatitis B virus infection management. Charre C, Levrero M, Zoulim F, Scholtès
C. Antiviral Res. 2019 Sep;169:104553.
doi:10.1016/j.antiviral.2019.104553. Review.
Toll-like receptor 3
downregulation is an escape mechanism from apoptosis during
hepatocarcinogenesis. Bonnin M,...., Merle P,…., Lebecque S. J Hepatol. 2019
Jun 18. pii: S0168-8278(19)30351-4. doi: 0.1016/j.jhep.2019.05.031.
Alteration of splicing
factors' expression during liver disease progression: impact on hepatocellular
carcinoma outcome. Wang H,..., Merle P,..., Soussan P. Hepatol Int. 2019
Jul;13(4):454-467. doi: 10.1007/s12072-019-09950-7.
Tumour-specific
amplitude-modulated radiofrequency electromagnetic fields induce
differentiation of hepatocellular carcinoma via targeting Ca(v)3.2 T-type
voltage-gated calcium channels and Ca(2+) influx. Jimenez H,., Merle P,.,
Pasche BC. EBioMedicine. 2019 Jun;44:209-224.
doi:10.1016/j.ebiom.2019.05.034.
In vitro transformation
of primary human hepatocytes: Epigenetic changes and stemness properties. Pez F, Gifu P,
Degli-Esposti D, Fares N, Lopez A, Lefrançois L, Michelet M, Rivoire M, Bancel
B, Sylla BS, Herceg Z, Merle P, Caron de Fromentel C. Exp Cell Res. 2019 Nov
15;384(2):111643. doi: 10.1016/j.yexcr.2019.111643.
Schwann cells support
oncogenic potential of pancreatic cancer cells through TGFβ signaling. Roger E, Martel S,...,
Mohkam K, Mabrut JY,..., Bartholin L. Cell Death Dis. 2019 Nov 25;10(12):886.
doi: 10.1038/s41419-019-2116-x.
2018
Targeting a phospho-STAT3-miRNAs pathway
improves vesicular hepatic steatosis in an in vitro and in vivo model. Belloni L,…, Guerrieri F,…, Levrero M, Pediconi N. Sci
Rep. 2018 Sep;8(1):13638. doi: 10.1038/s41598-018-31835-2.
Combining amplicon sequencing and
metabolomics in cirrhotic patients highlights distinctive microbiota features
involved in bacterial translocation, systemic inflammation and hepatic
encephalopathy. Iebba V, Guerrieri F, Di
Gregorio V, Levrero M, Gagliardi A, Santangelo F, Sobolev AP, Circi S,
Giannelli V, Mannina L, Schippa S, Merli M. Sci Rep. 2018 May;8:8210.
doi: 10.1038/s41598-018-26509-y.
miR-135a-5p-mediated downregulation of
protein tyrosine phosphatase receptor delta is a candidate driver of
HCV-associated hepatocarcinogenesis. Van Renne N,…, Zeisel MB,…, Lupberger J.
Gut. 2018 Feb; 67(5):953-962. doi: 10.1136/gutjnl-2016-312270.
Hepatocellular carcinoma-associated
depletion of the netrin-1 receptor Uncoordinated Phenotype-5A (UNC5A) skews the
hepatic unfolded protein response towards prosurvival outcomes. Barnault R, Lahlali T,
Plissonnier ML, Romero-López C, Laverdure N, Ducarouge B, Rivoire M,
Mehlen P, Zoulim F, Parent R. Biochem Biophys Res Commun. 2018 Jan;495(4):2425-2431. doi: 10.1016/j.bbrc.2017.12.129.
Hepatitis B Virus Evasion From Cyclic
Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human
Hepatocytes. Verrier ER,…, Zeisel MB,…, Baumert TF. Hepatology. 2018
Nov;68(5):1695-1709. doi: 10.1002/hep.30054.
Enteric Delivery of Regenerating Family
Member 3 alpha Alters the Intestinal Microbiota and Controls Inflammation in
Mice With Colitis. Darnaud M,…, Guerrieri F,…, Faivre J. Gastroenterology. 2018
Mar;154(4):1009-1023.e14. doi: 10.1053/j.gastro.2017.11.003.
A new signaling cascade
linking BMP4, BMPR1A, ΔNp73 and NANOG impacts on stem-like
human cell properties and patient outcome. Voeltzel T, Flores-Violante
M,..., Caron de Fromentel C, Maguer-Satta V. Cell Death Dis. 2018 Sep
27;9(10):1011. doi: 10.1038/s41419-018-1042-7.
Hepatitis B and hepatitis D virus
infections in the Central African Republic, twenty-five years after a fulminant
hepatitis outbreak, indicate continuing spread in asymptomatic young adults.
Komas NP, Ghosh S,..., Merle P,..., Cortay JC, Kay AC, Dény P. PLoS Negl Trop
Dis. 2018 Apr 26;12(4):e0006377. doi: 10.1371/journal.pntd.0006377.
Humanisation
of a claudin-1-specific monoclonal antibody for clinical prevention and cure of
HCV infection without escape. Colpitts CC, Tawar RG, Mailly L, Thumann C,
Heydmann L, Durand SC, Xiao F, Robinet E, Pessaux P, Zeisel MB, Baumert TF.
Gut. 2018 Apr;67(4):736-745. doi: 10.1136/gutjnl-2016-312577.Perspectives and
limitations for nucleo(t)side analogs in future HBV therapies. Levrero M, Subic
M, Villeret F, Zoulim F. Curr Opin Virol. 2018 Jun;30:80-89. doi:
10.1016/j.coviro.2018.04.006. Review.
Hepatitis
B. Zoulim F, Levrero M, Testoni B. Nat
Rev Gastroenterol Hepatol. 2018 Sep; doi: 10.1038/s41575-018-0060-3. Review.
[Hepatitis
delta virus replication and the role of the small hepatitis delta protein
S-HDAg]. Abeywickrama-Samarakoon N, Cortay JC,
Sureau C, Alfaiate D, Levrero M, Dény P. Med Sci (Paris). 2018
Oct;34(10):833-841. doi: 10.1051/medsci/2018209. Review.
Non-Coding
RNAs and Hepatitis C Virus-Induced Hepatocellular Carcinoma. Plissonnier ML, Herzog K, Levrero M, Zeisel MB. Viruses.
2018 Oct;10(11). pii: E591. doi: 10.3390/v10110591. Review.
Tight junction proteins in
gastrointestinal and liver disease. Zeisel MB,
Dhawan P, Baumert TF. Gut 2018 Oct; pii: gutjnl-2018-316906. doi:
10.1136/gutjnl-2018-316906. Review.
miR-122-regulated metabolic circuits:
micro-management of lipid metabolism in the human liver. Zeisel MB,
Plissonnier ML, Levrero M. Non-Coding
RNA Investigation 2018 Oct;10(11). pii: E591. doi: 10.3390/v10110591. Review.
Hepatitis C Virus (HCV)-Apolipoprotein
Interactions and Immune Evasion and Their Impact on HCV Vaccine Design. Wrensch F, Crouchet E, Ligat G, Zeisel MB, Keck ZY,
Foung SKH, Schuster C, Baumert TF. Front Immunol. 2018 Jun;9:1436. doi:
10.3389/fimmu.2018.01436. Review.
Host-targeting therapies for hepatitis C
virus infection: current developments and future applications. Crouchet E, Wrensch F, Schuster C, Zeisel MB, Baumert
TF. Therap Adv Gastroenterol. 2018 Mar 21;11:1756284818759483. doi:
10.1177/1756284818759483. eCollection 2018. Review.
[Risk of hepatocellular carcinoma after
hepatitis C virus cure with direct-acting antivirals: the next challenges]. Hamdane N, Baumert TF, Zeisel MB. Med Sci
(Paris). 2018 May;34(5):391-394. doi: 10.1051/medsci/20183405007. Review.
2017
PRMT5 Restricts Hepatitis B Virus
Replication via Epigenetic Repression of cccDNA Transcription and Interference
with pgRNA Encapsidation. Zhang W, Chen J, Wu M, Zhang X, Zhang M, Yue L, Li Y,
Liu J, Li B, Shen F, Wang Y, Bai L, Protzer U, Levrero M, Yuan Z. Hepatology.
2017 Feb 25. doi: 10.1002/hep.29133.
Genome-wide identification of direct HBx
genomic targets. Guerrieri F, Belloni L, D'Andrea D, Pediconi N, Le Pera L,
Testoni B, Scisciani C, Floriot O, Zoulim F, Tramontano A, Levrero M. BMC
Genomics. 2017 Feb 17;18(1):184. doi: 10.1186/s12864-017-3561-5.
Targeting mitochondrial dysfunction can
restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic
hepatitis B. Fisicaro P, Barili V, Montanini B, Acerbi G, Ferracin M, Guerrieri
F, Salerno D, Boni C, Massari M, Cavallo MC, Grossi G, Giuberti T, Lampertico
P, Missale G, Levrero M, Ottonello S, Ferrari C. Nat Med. 2017 Feb 6. doi:
10.1038/nm.4275.
Reciprocal antagonism
between the netrin-1 receptor uncoordinated-phenotype-5A (UNC5A) and the
hepatitis C virus. Plissonnier ML,
Lahlali T, Raab M, Michelet M, Romero-López C, Rivoire M, Strebhardt K,
Durantel D, Levrero M, Mehlen P, Zoulim F, Parent R. Oncogene. 2017 Nov;36(48):6712-6724. doi: 10.1038/onc.2017.271.
Cell death and
restoration of TRAIL-sensitivity by ciglitazone in resistant cervical cancer
cells. Plissonnier ML, Fauconnet S, Bittard H,
Mougin C, Rommelaere J, Lascombe I. Oncotarget. 2017 Nov;
8(64):107744-107762. doi: 10.18632/oncotarget.22632.
Detection of the
hepatitis B virus (HBV) covalently-closed-circular DNA (cccDNA) in mice
transduced with a recombinant AAV-HBV vector. Lucifora J,…, Levrero M,…, Durantel D. Antiviral Res.
2017 Sep;145:14-19. doi: 10.1016/j.antiviral.2017.07.006.
Metformin-inducedablation of microRNA
21-5p releases Sestrin-1 and CAB39L antitumoral activities. Pulito C,…, Levrero M,…, Blandino G. Cell
Discov. 2017 Jul;3:17022. doi: 10.1038/celldisc.2017.22.
Plasmodium P36 determines host cell
receptor usage during sporozoite invasion. Manzoni
G.,…, Zeisel MB,…, Silvie O. eLife. 2017 May;6. pii: e25903. doi:
10.7554/eLife.25903.
Targeted deep sequencing of plasma
circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential
epigenetic biomarkers for hepatocellular carcinoma. Holmila R, Sklias A, Muller
DC, Degli Esposti D, Guilloreau P, Mckay J, Sangrajrang S, Srivatanakul P,
Hainaut P, Merle P, Herceg Z, Nogueira da Costa A. PLoS One. 2017 Mar 23;12(3):e0174265.
doi: 10.1371/journal.pone.0174265.
DNA demethylation induces SALL4 gene
re-expression in subgroups of hepatocellular carcinoma associated with
Hepatitis B or C virus infection. Fan H, Cui Z, Zhang H, Mani SK, Diab A,
Lefrancois L, Fares N, Merle P, Andrisani O. Oncogene. 2017 Apr
27;36(17):2435-2445. doi: 10.1038/onc.2016.399.
Polymorphic multiple hepatocellular
adenoma including a non-steatotic HNF1α-inactivated
variant. Mohkam K, Darnis B, Cazauran JB, Rode A, Manichon AF, Ducerf C, Bancel
B, Mabrut JY. Hepatobiliary Pancreat Dis Int. 2017 Oct 15;16(5):552-555. doi:
10.1016/S1499-3872(17)60058-4.
Relevance of the porcine model of
hepatectomy for studying portal inflow modulation by splenectomy. Darnis B,
Mohkam K, Mabrut JY. J Surg Res. 2017 Sep;217:232-234. doi:
10.1016/j.jss.2017.02.074.
Challenges to a Cure for HBV Infection. Testoni B, Levrero M, Zoulim F. Semin Liver
Dis. 2017 Aug;37(3):231-242. doi: 10.1055/s-0037-1606212. Review.
Advancing the clinical
development of hepatitis C virus host-targeting agents. Zeisel MB and Baumert TF. The Lancet. 2017
Feb;389(10070):674-675. doi: 10.1016/S0140-6736(17)30043-0. Review.
Towards novel
immunocompetent animal models for hepatitis B virus infection. Mailly L, Zeisel MB, Baumert TF. Hepatology. 2017
Sep;66(3):691-693. doi: 10.1002/hep.29249. Review.
2016
Intrahepatic innate immune response
pathways are downregulated in untreated chronic hepatitis B patients. Lebossé
F, Testoni B, Fresquet J, Facchetti F, Galmozzi E, Fournier M, Hervieu V,
Berthillon P, Berby F, Bordes I, Durantel D, Levrero M, Lampertico P, Zoulim F.
J Hepatol. 2016 Dec 30. pii: S0168-8278(16)30757-7. doi:
10.1016/j.jhep.2016.12.024.
HDV RNA replication is associated with
HBV repression and interferon-stimulated genes induction in super-infected
hepatocytes. Alfaiate D, Lucifora J, Abeywickrama-Samarakoon N, Michelet M,
Testoni B, Cortay JC, Sureau C, Zoulim F, Dény P, Durantel D. Antiviral Res.
2016 Dec;136:19-31. doi: 10.1016/j.antiviral.2016.10.006.
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic
remodelling at interferon stimulated genes. Testoni B, Durantel D, Lebossé F,
Fresquet J, Helle F, Negro F, Donato MF, Levrero M, Zoulim F. Gut. 2016
Apr;65(4):672-82. doi: 10.1136/gutjnl-2014-309011.
Solute carrier NTCP regulates innate
antiviral immune responses targeting hepatitis C virus infection of
hepatocytes. Verrier ER, Colpitts CC,…, Zeisel MB, Baumert TF. Cell Rep. 2016
Oct 25;17(5):1357-1368. doi: 10.1016/j.celrep.2016.09.084.
Broad neutralization of hepatitis C
virus-resistant variants by Civacir hepatitis C immunoglobulin. Tawar RG,
Heydmann L, Bach C, Schüttrumpf J, Chavan S, King BJ, McClure CP, Ball JK,
Pessaux P, Habersetzer F, Bartenschlager R, Zeisel MB, Baumert TF. Hepatology.
2016 Nov;64(5):1495-1506. doi: 10.1002/hep.28767.
Hepatitis C Virus-Induced Upregulation
of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates
Metabolic Pathways Associated with Liver Disease Pathogenesis. Bandiera S,
Pernot S, El Saghire H, Durand SC, Thumann C, Crouchet E, Ye T, Fofana I, Oudot
MA, Barths J, Schuster C, Pessaux P, Heim MH, Baumert TF, Zeisel MB. J Virol.
2016 Jun 24;90(14):6387-6400. doi: 10.1128/JVI.00619-16.
A targeted functional RNA interference
screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses.
Verrier ER, Colpitts CC, .. Zeisel MB, Baumert TF. Hepatology. 2016
Jan;63(1):35-48. doi: 10.1002/hep.28013.HBV cure: why, how, when? Levrero M,
Testoni B, Zoulim F. Curr Opin Virol. 2016 Jun;18:135-43. doi:
10.1016/j.coviro.2016.06.003.
The histone deacetylase inhibiting drug
Entinostat induces lipid accumulation in differentiated HepaRG cells. Nunn AD,
Scopigno T, Pediconi N, Levrero M, Hagman H, Kiskis J, Enejder A. Sci Rep. 2016
Jun 20;6:28025. doi: 10.1038/srep28025.
EpCAM-regulated intramembrane
proteolysis induces a cancer stem cell-like gene signature in hepatitis B
virus-infected hepatocytes. Mani
SK, Zhang H, Diab A, Pascuzzi PE, Lefrançois L, Fares N, Bancel B, Merle P,
Andrisani O. J Hepatol. 2016
Nov;65(5):888-898. doi: 10.1016/j.jhep.2016.05.022.
RNA helicase DEAD box protein 5
regulates Polycomb repressive complex 2/Hox transcript antisense intergenic RNA
function in hepatitis B virus infection and hepatocarcinogenesis. Zhang H, Xing
Z, Mani SK, Bancel B, Durantel D, Zoulim F, Tran EJ, Merle P, Andrisani O.
Hepatology. 2016 Oct;64(4):1033-48. doi: 10.1002/hep.28698.
Identification of novel long non-coding
RNAs deregulated in hepatocellular carcinoma using RNA-sequencing. Esposti DD,
Hernandez-Vargas H, Voegele C, Fernandez-Jimenez N, Forey N, Bancel B, Le
Calvez-Kelm F, McKay J, Merle P, Herceg Z. Oncotarget. 2016 May
31;7(22):31862-77. doi: 10.18632/oncotarget.7364.
HBx triggers either cellular senescence
or cell proliferation depending on cellular phenotype. Idrissi ME, Hachem H,
Koering C, Merle P, Thénoz M, Mortreux F, Wattel E. J Viral Hepat. 2016
Feb;23(2):130-8. doi: 10.1111/jvh.12450.
Impact on antiviral resistance of E119V,
I222L and R292K substitutions in influenza A viruses bearing a group 2
neuraminidase (N2, N3, N6, N7 and N9). Gaymard A, Charles-Dufant A, Sabatier M,
Cortay JC, Frobert E, Picard C, Casalegno JS, Rosa-Calatrava M, Ferraris O,
Valette M, Ottmann M, Lina B, Escuret V. J Antimicrob Chemother. 2016 Nov;71(11):3036-3045.
Current treatments for chronic hepatitis
B virus infections. Zoulim F, Lebossé F, Levrero M. Curr Opin Virol. 2016
Jun;18:109-16. doi: 10.1016/j.coviro.2016.06.004. Review.
Aiming for cure in HBV and HDV
infection. Petersen J, Thompson AJ, Levrero M. J Hepatol. 2016
Oct;65(4):835-48. doi: 10.1016/j.jhep.2016.05.043. Review.
Mechanisms of HBV-induced hepatocellular
carcinoma. Levrero M, Zucman-Rossi J. J Hepatol. 2016 Apr;64(1 Suppl):S84-101.
doi: 10.1016/j.jhep.2016.02.021. Review.
Porcine models for the study of
small-for-size syndrome and portal inflow modulation: literature review and
proposal for a standardized nomenclature. Mohkam K, Darnis B, Mabrut JY. J
Hepatobiliary Pancreat Sci. 2016 Nov;23(11):668-680. doi: 10.1002/jhbp.396. Review.
The hepatitis D satellite virus of
hepatitis B virus: half-opening a new era to control viral infection?
Abeywickrama-Samarakoon N, Cortay JC, Dény P. Curr Opin Infect Dis. 2016
Dec;29(6):645-653. Review.
Cell
culture models for the investigation of hepatitis B and D virus infection.
Verrier ER, Colpitts CC, Schuster C, Zeisel MB, Baumert TF. Viruses. 2016 Sep
20;8(9). pii: E261. Review.
Hepatitis B virus: is a cure
possible? Zeisel MB, Baumert
TF. Expert Rev Clin Pharmacol. 2016 Sep;9(9):1129-30. doi:
10.1080/17512433.2016.1206466. Review.
2015
IL6 Inhibits HBV Transcription by
Targeting the Epigenetic Control of the Nuclear cccDNA Minichromosome. Palumbo
GA, Scisciani C, Pediconi N, Lupacchini L, Alfalate D, Guerrieri F, Calvo L,
Salerno D, Di Cocco S, Levrero M, Belloni L. PLoS One. 2015 Nov
18;10(11):e0142599. doi: 10.1371/journal.pone.0142599.
Expression and functionality of Toll-
and RIG-like receptors in HepaRG cells. Luangsay S, Ait-Goughoulte M, Michelet
M, Floriot O, Bonnin M, Gruffaz M, Rivoire M, Fletcher S, Javanbakht H,
Lucifora J, Zoulim F, Durantel D. J Hepatol. 2015 Nov;63(5):1077-85. doi:
10.1016/j.jhep.2015.06.022.
Targeted deep DNA methylation analysis
of circulating cell-free DNA in plasma using massively parallel semiconductor
sequencing. Vaca-Paniagua F, Oliver J, Nogueira da Costa A, Merle P, McKay J,
Herceg Z, Holmila R. Epigenomics. 2015;7(3):353-62. doi: 10.2217/epi.14.94.
PARP inhibition and the radiosensitizing
effects of the PARP inhibitor ABT-888 in in vitro hepatocellular carcinoma
models. Guillot C, Favaudon V, Herceg Z, Sagne C, Sauvaigo S, Merle P, Hall J,
Chemin I. BMC Cancer. 2014 Aug 20;14:603. doi: 10.1186/1471-2407-14-603.
Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for
HBV-related hepatocellular carcinoma. da Costa AN, Plymoth A,..., Merle P,
Beretta L, Hainaut P. Int J Cancer. 2015 Jan 1;136(1):172-81. doi:
10.1002/ijc.28953.
Subtotal hepatectomy in swine for studying
small-for-size syndrome and portal inflow modulation: is it reliable? Darnis B,
Mohkam K, Schmitt Z, Ledochowski S, Vial JP, Duperret S, Vogt C, Demian H,
Golse N, Mezoughi S, Ducerf C, Mabrut JY. HPB (Oxford). 2015 Oct;17(10):881-8.
doi: 10.1111/hpb.12434.
Disequilibrium of BMP2 levels in the
breast stem cell niche launches epithelial transformation by overamplifying
BMPR1B cell response. Chapellier M, Bachelard-Cascales E,..., Caron de
Fromentel C, Caux C, Blay J-Y, Iggo R, Maguer-Satta V. Stem Cell Reports. 2015
Feb 10;4(2):239-54. doi: 10.1016/j.stemcr.2014.12.007.
Protein-peptide arrays for detection of
specific anti-hepatitis D virus (HDV) genotype 1, 6, and 8 antibodies among
HDV-infected patients by surface plasmon resonance imaging. Villiers MB, Cortay
JC,..., Dény P. J Clin Microbiol. 2015 Apr;53(4):1164-71. doi:
10.1128/JCM.03002-14.
Towards
an HBV cure: state-of-the-art and unresolved questions--report of the ANRS
workshop on HBV cure. Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J,
Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B,
Cosset FL, Strick-Marchand H, Trépo C, Kao JH, Carrat F, Lacombe K, Schinazi
RF, Barré-Sinoussi F, Delfraissy JF, Zoulim F. Gut. 2015 Aug;64(8):1314-26.
doi: 10.1136/gutjnl-2014-308943. Review.